FULTON BANK, N.A. - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 15 filers reported holding Astellas Pharma Inc in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FULTON BANK, N.A. ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q2 2020$202,000
-5.6%
12,109
-12.3%
0.01%
-23.5%
Q1 2020$214,000
-27.9%
13,814
-19.7%
0.02%
-5.6%
Q4 2019$297,000
+21.7%
17,211
+0.2%
0.02%
+5.9%
Q3 2019$244,000
+11.9%
17,185
+12.1%
0.02%
+13.3%
Q2 2019$218,000
-2.2%
15,333
+2.8%
0.02%
-6.2%
Q1 2019$223,000
-14.2%
14,909
-26.9%
0.02%
-23.8%
Q4 2018$260,000
-36.4%
20,397
-13.1%
0.02%
-22.2%
Q3 2018$409,00023,4710.03%
Other shareholders
Astellas Pharma Inc shareholders Q3 2018
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 469,618$7,628,0000.31%
TODD ASSET MANAGEMENT LLC 193,500$3,148,0000.07%
SCOUT INVESTMENTS, INC. 225,247$3,665,0000.05%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 193,500$3,148,0000.03%
SILVERCREST ASSET MANAGEMENT GROUP LLC 113,135$1,838,0000.01%
Private Capital Group, LLC 924$15,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 35$1,0000.00%
IFP Advisors, Inc 40$1,0000.00%
First Horizon Advisors, Inc. 120$1,0000.00%
CAPTRUST FINANCIAL ADVISORS 3,790$62,0000.00%
View complete list of Astellas Pharma Inc shareholders